{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:02:21Z","timestamp":1784872941094,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Extra-transitional zone density (ETzD), a novel parameter is proposed to stratify the deviation of prostate specific antigen (PSA) due to structural change according to stromal hyperplasia of prostate. ETzD was conducted on a concept to estimate the PSA density (PSAD) after hypothetical enucleation of the transitional zone of an enlarged prostate by a non-linear regression prediction model with intrinsic linearity, from the retrospective analysis of PSA change observed actual enucleation by laser. The performance to predict the presence and severity of malignancy was validated by two cohorts of 3,440 prostate biopsies and 2,783 radical prostatectomy specimens. The performance of ETzD was compared with conventional parameters. The receiver operative curve of area under curve (AUC) of ETzD to predict the presence of malignacy was 0.862 (95% CI; 0.843~0.881), better than PSA, PSAD or transitional zone PSAD (TzPSAD). The AUC of ETzD to predict an unfavorable cancer among prostate cancer patients was 0.736 (95% CI; 0.705~0.768), which performs better than PSA and comparable to PSAD or TzPSAD. In summary, the performance of ETzD as a universal parameter to quantify the oncological hazard of a prostate was validated and the superiority to conventional parameters was verified.<\/jats:p>","DOI":"10.1038\/s41598-018-36602-x","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T11:02:48Z","timestamp":1548414168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma"],"prefix":"10.1038","volume":"9","author":[{"given":"Jung Jun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Seok","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"36602_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0022-5347(17)38491-4","volume":"145","author":"JE Oesterling","year":"1991","unstructured":"Oesterling, J. E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145, 907\u2013923 (1991).","journal-title":"J Urol"},{"key":"36602_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5213\/inj.2015.19.4.278","volume":"19","author":"HS Ryoo","year":"2015","unstructured":"Ryoo, H. S. et al. Efficacy of holmium laser enucleation of the prostate based on patient preoperative characteristics. International neurourology journal 19, 278 (2015).","journal-title":"International neurourology journal"},{"key":"36602_CR3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.6004\/jnccn.2013.0174","volume":"11","author":"JL Mohler","year":"2013","unstructured":"Mohler, J. L. et al. Prostate cancer, version 1.2014. J Natl Compr Canc Netw 11, 1471\u20131479 (2013).","journal-title":"J Natl Compr Canc Netw"},{"key":"36602_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1464-410X.2005.05788_3.x","volume":"96","author":"SR Bott","year":"2005","unstructured":"Bott, S. R., Henderson, A., Laing, R. W., Montgomery, B. S. & Langley, S. E. Technical considerations when obtaining and interpreting prostatic biopsies from men with a suspicion of early prostate cancer. BJU Int 96, 686 (2005).","journal-title":"BJU Int"},{"key":"36602_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","volume":"147","author":"MC Benson","year":"1992","unstructured":"Benson, M. C. et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147, 815\u2013816 (1992).","journal-title":"J Urol"},{"key":"36602_CR6","first-page":"5","volume":"65","author":"T Roumeguere","year":"1997","unstructured":"Roumeguere, T., Zlotta, A. R., Djavan, B. R., Marberger, M. & Schulman, C. C. PSA level of the transitional zone: a new marker especially reliable for the detection of prostatic cancer. Acta Urol Belg 65, 5\u20139 (1997).","journal-title":"Acta Urol Belg"},{"key":"36602_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/aja.2013.100","volume":"15","author":"SC Kuo","year":"2013","unstructured":"Kuo, S. C. et al. Chinese nomogram to predict probability of positive initial prostate biopsy: a study in Taiwan region. Asian J Androl 15, 780\u2013784 (2013).","journal-title":"Asian J Androl"},{"key":"36602_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000343528","volume":"6","author":"CJ DiBlasio","year":"2013","unstructured":"DiBlasio, C. J. et al. Nomogram to predict prostate cancer diagnosis on primary transrectal ultrasound-guided prostate biopsy in a contemporary series. Curr Urol 6, 141\u2013145 (2013).","journal-title":"Curr Urol"},{"key":"36602_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/aja.2012.111","volume":"15","author":"P Tang","year":"2013","unstructured":"Tang, P. et al. A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer. Asian J Androl 15, 129\u2013133 (2013).","journal-title":"Asian J Androl"},{"key":"36602_CR10","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1111\/bju.12306","volume":"113","author":"LS Marks","year":"2014","unstructured":"Marks, L. S. Improving risk stratification in patients with prostate cancer managed by active surveillance: nomogram predicting the risk of biopsy progression. BJU Int 113, E13\u201314 (2014).","journal-title":"BJU Int"},{"key":"36602_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/bjc.2012.400","volume":"107","author":"LM Wong","year":"2012","unstructured":"Wong, L. M. et al. International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy. Br J Cancer 107, 1467\u20131473 (2012).","journal-title":"Br J Cancer"},{"key":"36602_CR12","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.urology.2013.01.067","volume":"81","author":"S Freedland","year":"2013","unstructured":"Freedland, S. & Mithal, P. Editorial comment. Urology 81, 1208 (2013).","journal-title":"Urology"},{"key":"36602_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2217\/fon.09.121","volume":"5","author":"SF Shariat","year":"2009","unstructured":"Shariat, S. F., Kattan, M. W., Vickers, A. J., Karakiewicz, P. I. & Scardino, P. T. Critical review of prostate cancer predictive tools. Future Oncol 5, 1555\u20131584 (2009).","journal-title":"Future Oncol"},{"key":"36602_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1590\/S1677-5538.IBJU.2014.02.05","volume":"40","author":"AJ Bastian Jr.","year":"2014","unstructured":"Bastian, A. J. Jr. et al. External validation of a Brazilian predictive nomogram for pathologic outcomes following radical prostatectomy in tertiary teaching institutions: the USP nomograms. Int Braz J Urol 40, 161\u2013171 (2014).","journal-title":"Int Braz J Urol"},{"key":"36602_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/21681805.2014.920415","volume":"49","author":"R Turo","year":"2015","unstructured":"Turo, R. et al. Do prostate cancer nomograms give accurate information when applied to European patients? Scand J Urol 49, 16\u201324 (2015).","journal-title":"Scand J Urol"},{"key":"36602_CR16","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1111\/bju.12554","volume":"114","author":"SY Wang","year":"2014","unstructured":"Wang, S. Y. et al. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer. BJU Int 114, E18\u201324 (2014).","journal-title":"BJU Int"},{"key":"36602_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5489\/cuaj.370","volume":"6","author":"C Morash","year":"2012","unstructured":"Morash, C. PSA density: The comeback kid? Can Urol Assoc J 6, 51\u201352 (2012).","journal-title":"Can Urol Assoc J"},{"key":"36602_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/iju.12326","volume":"21","author":"TH Kim","year":"2014","unstructured":"Kim, T. H. et al. Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols. Int J Urol 21, 377\u2013381 (2014).","journal-title":"Int J Urol"},{"key":"36602_CR19","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/sim.5328","volume":"31","author":"OV Demler","year":"2012","unstructured":"Demler, O. V., Pencina, M. J. & D\u2019Agostino, R. B. Sr. Misuse of DeLong test to compare AUCs for nested models. Stat Med 31, 2577\u20132587 (2012).","journal-title":"Stat Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36602-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36602-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36602-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:11:30Z","timestamp":1671253890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36602-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["36602"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-36602-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"11 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"770"}}